|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 309/10 | |
| A61K 31/351 | |||
| A61P 3/10 |
| (11) | Patento numeris | 3466939 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17802110.1 |
| Europos patento paraiškos padavimo data | 2017-05-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-02-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/085295 |
| Data | 2017-05-22 |
| (87) | Numeris | WO 2017/202264 |
| Data | 2017-11-30 |
| (30) | Numeris | Data | Šalis |
| 201610347924 | 2016-05-24 | CN |
| (72) |
LI, Xiang, CN
HE, Lei, CN
YU, Jun, CN
WANG, Jinjia, CN
DU, Zuyin, CN
|
| (73) |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.,
Economic and Technological Development Zone Lianyungang, Jiangsu 222047,
CN
|
| (54) | NEW DAPAGLIFLOZIN CRYSTAL FORM AND PREPARATION METHOD AND USE THEREOF |
| NEW DAPAGLIFLOZIN CRYSTAL FORM AND PREPARATION METHOD AND USE THEREOF |